Genfit S.A. (EPA:GNFT)
France · Delayed Price · Currency is EUR 5.31
+0.06 (1.14%)
Jan 9, 2026, 5:35 PM CET
Genfit Market Cap
Genfit has a market cap or net worth of €264.41 million as of January 9, 2026. Its market cap has increased by 50.00% in one year.
Market Cap
264.41M
Enterprise Value
295.82M
Revenue
45.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
€5.31
Market Cap Chart
Since December 20, 2006, Genfit's market cap has increased from 146.07M to 264.41M, an increase of 81.02%. That is a compound annual growth rate of 3.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 264.41M | 0.85% |
| Dec 31, 2025 | 262.17M | 48.73% |
| Dec 31, 2024 | 176.27M | 0.17% |
| Dec 29, 2023 | 175.98M | -10.69% |
| Dec 30, 2022 | 197.03M | -8.19% |
| Dec 31, 2021 | 214.62M | 38.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 125.76B |
| Sanofi | 100.86B |
| Sartorius Stedim Biotech | 21.47B |
| bioMérieux | 13.42B |
| Eurofins Scientific SE | 12.17B |
| Ipsen | 10.40B |
| ABIVAX Société Anonyme | 7.72B |
| Virbac | 3.03B |